Home LiteratureArticle Details
PMID: 1500859 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

The Journal of experimental medicine ·Vol. 176 ·No. 2 ·1992-08-01 ·Pages 531-41

Voss SD, Sondel PM, Robb RJ

Abstract

Interleukin 2 (IL-2) receptors expressed on the surface of activated T cells and natural killer (NK) cells exhibit a variety of affinity states depending on their subunit composition. Low-affinity binding is associated with a 55-kDa alpha chain, intermediate-affinity binding with a 70-75-kD beta chain, and high-affinity binding with a bimolecular complex of the alpha and beta subunits. In a previous study of the IL-2 receptors expressed on NK cells obtained from cancer patients after in vivo IL-2 therapy, we documented a discrepancy between the level of beta chain and the level of intermediate-affinity IL-2 binding sites expressed on the cell surface. Based on this result, we postulated that formation of intermediate-affinity receptor sites required a component in addition to the beta chain, and that this component was present at limiting levels in the patient NK cells. In the present study we have examined the structure of the intermediate-affinity receptor complex using monoclonal antibodies that recognize the beta chain, but that do not interfere with its ability to bind IL-2. Evidence is presented establishing the physical association of a novel protein of 64 kD with the beta chain in intermediate-affinity IL-2 binding sites. This molecule, termed IL-2R gamma chain, coprecipitated with beta chains prepared from cells that had been incubated with IL-2, but was undetectable in immunoprecipitates prepared in the absence of IL-2. Examination of gamma chain expression in post-IL-2 therapy NK cells, where only low levels of intermediate-affinity IL-2 binding were detectable, revealed that the gamma chain was associated with, on average, only 10-12% of the beta chains expressed on such cells. This contrasted with approximately equal levels of beta and gamma chain expression on YT cells, a cell line that has both high levels of cell surface beta chain expression and high levels of IL-2 binding. Thus, the ratio of gamma chain to beta chain present in the immunoprecipitates roughly correlated with the proportion of beta chain involved in intermediate-affinity receptor sites. This result suggests that the 64-kD gamma chain is the component responsible for regulating the affinity of IL-2 association with the beta subunit. By further defining the structural components necessary for IL-2 receptor formation, these studies provide additional insight into mechanisms whereby lymphocytes might regulate their responsiveness to IL-2.

MeSH Terms
Animals Antibodies, Monoclonal/immunology CHO Cells Cell Line Cloning, Molecular Cricetinae Electrophoresis, Gel, Two-Dimensional Flow Cytometry Humans Interleukin-2/physiology Killer Cells, Natural/immunology,metabolism Lymphocyte Activation Receptors, Interleukin-2/genetics,immunology,metabolism
Chemicals
Antibodies, Monoclonal Interleukin-2 Receptors, Interleukin-2
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Voss S D
Department of Human Oncology, University of Wisconsin Clinical Sciences Center, Madison 53792.
Sondel P M
Robb R J
References (49)
49 references, click to expand
  1. The beta-chain of the IL-2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells.
    J Immunol. 1989 Oct 15;143(8):2530-3 PMID: 2477446
  2. Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells.
    Proc Natl Acad Sci U S A. 1990 Mar;87(6):2274-8 PMID: 2138330
  3. Partial agonist/antagonist mouse interleukin-2 proteins indicate that a third component of the receptor complex functions in signal transduction.
    EMBO J. 1990 Dec;9(12):3899-905 PMID: 2249656
  4. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.
    J Biol Chem. 1990 Feb 25;265(6):3561-7 PMID: 2303462
  5. Characterization of the heterodimeric complex of human IL-2 receptor alpha.beta chains reconstituted in a mouse fibroblast cell line, L929.
    J Immunol. 1990 Oct 1;145(7):2177-82 PMID: 2398275
  6. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies.
    Proc Natl Acad Sci U S A. 1989 Mar;86(6):1982-6 PMID: 2467293
  7. IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody.
    Int Immunol. 1989;1(4):373-7 PMID: 2489034
  8. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
    J Immunol. 1985 Mar;134(3):1623-30 PMID: 2578514
  9. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.
    Cell. 1989 Dec 1;59(5):837-45 PMID: 2590941
  10. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.
    J Exp Med. 1989 Apr 1;169(4):1323-32 PMID: 2784485
  11. Two-dimensional analysis of interleukin 2-regulated tyrosine kinase activation mediated by the p70-75 beta subunit of the interleukin 2 receptor.
    J Biol Chem. 1989 Jul 25;264(21):12562-7 PMID: 2787319
  12. Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.
    Proc Natl Acad Sci U S A. 1987 Apr;84(7):2002-6 PMID: 3031660
  13. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.
    Science. 1986 Nov 14;234(4778):859-63 PMID: 3095922
  14. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
    Nature. 1987 Jun 11-17;327(6122):518-22 PMID: 3108674
  15. Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor.
    J Exp Med. 1987 Oct 1;166(4):1156-61 PMID: 3116145
  16. Interleukin-2: inception, impact, and implications.
    Science. 1988 May 27;240(4856):1169-76 PMID: 3131876
  17. Co-internalization of the p55 and p70 subunits of the high-affinity human interleukin 2 receptor. Evidence for a stable ternary receptor complex.
    J Exp Med. 1988 Nov 1;168(5):1923-8 PMID: 3263468
  18. Iodination of the normal and buried tyrosyl residues of lysozyme. II. Spectrophotometric analysis.
    Biochemistry. 1966 Mar;5(3):867-71 PMID: 5911298
  19. An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex.
    J Immunol. 1992 Apr 1;148(7):2154-8 PMID: 1545122
  20. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Cancer Res. 1990 May 1;50(9):2683-91 PMID: 1691679
  21. Monoclonal antibodies defining distinct epitopes of the human IL-2 receptor beta chain and their differential effects on IL-2 responses.
    J Immunol Methods. 1991 Aug 28;142(1):61-72 PMID: 1717594
  22. Quantitative characterization of the intrinsic ligand-binding affinity of the interleukin 2 receptor beta chain and its modulation by the alpha chain and a second affinity-modulating element.
    Lymphokine Cytokine Res. 1991 Jun;10(3):219-24 PMID: 1883916
  23. Putative gamma-subunit of the IL-2 receptor is detected in low, intermediate, and high affinity IL-2 receptor-bearing cells.
    J Immunol. 1990 Jul 1;145(1):155-60 PMID: 1972716
  24. Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor beta chain and receptor-associated proteins.
    Cell Regul. 1991 Jan;2(1):73-85 PMID: 2007186
  25. IL-2-induced signal transduction: involvement of tyrosine kinase and IL-2 receptor gamma chain.
    Lymphokine Res. 1990 Winter;9(4):539-42 PMID: 2090880
  26. The evidence for the IL-2 receptor beta chain processing from p70 to p75.
    Int Immunol. 1990;2(5):469-72 PMID: 2128185
  27. Autoradiography using storage phosphor technology.
    Electrophoresis. 1990 May;11(5):355-60 PMID: 2194789
  28. Molecular cloning and expression of an IL-6 signal transducer, gp130.
    Cell. 1990 Dec 21;63(6):1149-57 PMID: 2261637
  29. The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms.
    J Immunol. 1990 Jul 15;145(2):599-606 PMID: 2365996
  30. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells.
    Nature. 1989 Dec 14;342(6251):803-5 PMID: 2532305
  31. The multi-subunit interleukin-2 receptor.
    Annu Rev Biochem. 1989;58:875-911 PMID: 2673025
  32. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.
    Science. 1989 May 5;244(4904):551-6 PMID: 2785715
  33. Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.
    J Exp Med. 1987 Apr 1;165(4):1201-6 PMID: 3031195
  34. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.
    J Exp Med. 1987 Jan 1;165(1):223-38 PMID: 3098894
  35. The interleukin 2 receptor. Functional consequences of its bimolecular structure.
    J Exp Med. 1987 Oct 1;166(4):1055-69 PMID: 3116143
  36. Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2.
    J Biol Chem. 1988 May 25;263(15):6956-9 PMID: 3259228
  37. Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.
    J Natl Cancer Inst. 1988 Nov 16;80(18):1451-61 PMID: 3263508
  38. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.
    J Exp Med. 1984 Oct 1;160(4):1126-46 PMID: 6090574
  39. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression.
    J Immunother (1991). 1992 Feb;11(2):111-8 PMID: 1571333
  40. High gradient magnetic cell separation with MACS.
    Cytometry. 1990;11(2):231-8 PMID: 1690625
  41. Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.
    J Exp Med. 1990 Oct 1;172(4):1101-14 PMID: 1698909
  42. Regulation of the interleukin 2 receptor complex tyrosine kinase activity in vitro.
    Cytokine. 1991 Sep;3(5):428-38 PMID: 1751780
  43. A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor.
    J Immunol. 1991 Aug 15;147(4):1253-60 PMID: 1869821
  44. Biochemical evidence for a third chain of the interleukin-2 receptor.
    J Biol Chem. 1991 Nov 25;266(33):22186-91 PMID: 1939240
  45. The interleukin-2 receptor.
    J Biol Chem. 1991 Feb 15;266(5):2681-4 PMID: 1993646
  46. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.
    Science. 1991 Jun 14;252(5012):1523-8 PMID: 2047859
  47. An associated molecule, p64, with high-affinity interleukin 2 receptor.
    Int Immunol. 1990;2(5):477-80 PMID: 2085489
  48. Interleukin 2 (IL-2)-induced tyrosine phosphorylation of IL-2 receptor p75.
    J Exp Med. 1990 Mar 1;171(3):637-44 PMID: 2106566
  49. A new cytokine receptor superfamily.
    Trends Biochem Sci. 1990 Jul;15(7):265-70 PMID: 2166365
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1992-08-01
Pages
531-41
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2119323
Subset
IM
Grants
NCI NIH HHS · CA-32685 · United States
NCI NIH HHS · CA-53441 · United States
NCI NIH HHS · CM-87290 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]